微脉冲™经巩膜环形光凝术在马患者中的应用：四匹马的病例系列。

IF 1.7 4区农林科学 Q2 VETERINARY SCIENCES

Veterinary ophthalmology Pub Date : 2025-03-01 Epub Date: 2024-01-15 DOI:10.1111/vop.13184

A M Sturbaum, K J Kaiser, J S Riesberg

{"title":"微脉冲™经巩膜环形光凝术在马患者中的应用：四匹马的病例系列。","authors":"A M Sturbaum, K J Kaiser, J S Riesberg","doi":"10.1111/vop.13184","DOIUrl":null,"url":null,"abstract":"Objective: To describe the clinical application and outcome of MicroPulse™ transscleral cyclophotocoagulation (MP-TSCPC) treatment in horses with glaucoma.Animals studied: Four client-owned horses with primary (n = 2) or secondary (n = 2) glaucoma.Methods: Horses were treated with MP-TSCPC under standing sedation with a minimum of 30 days of follow-up (range 30-1241 days). Affected eyes were treated with a 31.3% duty cycle and 3000 mW laser power for a total of 180 s. Data collected included signalment, pre- and post-procedure intraocular pressures (IOPs), laser settings, medications, complications, and repeat therapy.Results: Four horses (5 eyes) received at least one treatment with MP-TSCPC. Mean preoperative IOP was 44 mmHg (range 33-49 mmHg). The immediate mean postoperative IOP was 34 mmHg (4 eyes; range 19-55 mmHg). At 1 week, IOP was 38 mmHg (5 eyes; range 21-80 mmHg), at 2 weeks was 40 mmHg (3 eyes, range 17-80 mmHg), at 1 month was 35 mmHg (5 eyes; range 20-50 mmHg), at 3 months was 18 mmHg (2 eyes; range 14-21 mmHg), at 6 months was 35 mmHg (2 eyes; range 30-39 mmHg), and at >300 days was 24 mmHg (3 eyes; range 18-29 mmHg). Complications included corneal ulceration (n = 1 eye), uncontrolled IOP (n = 3 eyes), and need for repeat treatment (n = 2 eyes).Conclusions: MP-TSCPC used with the above-described settings was unsuccessful in treating the majority of cases. Future studies should be targeted at primary glaucoma cases and with use of alternative laser settings.","PeriodicalId":23836,"journal":{"name":"Veterinary ophthalmology","volume":" ","pages":"465-473"},"PeriodicalIF":1.7000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"MicroPulse™ transscleral cyclophotocoagulation in the equine patient: A case series of four horses.\",\"authors\":\"A M Sturbaum, K J Kaiser, J S Riesberg\",\"doi\":\"10.1111/vop.13184\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Objective: To describe the clinical application and outcome of MicroPulse™ transscleral cyclophotocoagulation (MP-TSCPC) treatment in horses with glaucoma.Animals studied: Four client-owned horses with primary (n = 2) or secondary (n = 2) glaucoma.Methods: Horses were treated with MP-TSCPC under standing sedation with a minimum of 30 days of follow-up (range 30-1241 days). Affected eyes were treated with a 31.3% duty cycle and 3000 mW laser power for a total of 180 s. Data collected included signalment, pre- and post-procedure intraocular pressures (IOPs), laser settings, medications, complications, and repeat therapy.Results: Four horses (5 eyes) received at least one treatment with MP-TSCPC. Mean preoperative IOP was 44 mmHg (range 33-49 mmHg). The immediate mean postoperative IOP was 34 mmHg (4 eyes; range 19-55 mmHg). At 1 week, IOP was 38 mmHg (5 eyes; range 21-80 mmHg), at 2 weeks was 40 mmHg (3 eyes, range 17-80 mmHg), at 1 month was 35 mmHg (5 eyes; range 20-50 mmHg), at 3 months was 18 mmHg (2 eyes; range 14-21 mmHg), at 6 months was 35 mmHg (2 eyes; range 30-39 mmHg), and at >300 days was 24 mmHg (3 eyes; range 18-29 mmHg). Complications included corneal ulceration (n = 1 eye), uncontrolled IOP (n = 3 eyes), and need for repeat treatment (n = 2 eyes).Conclusions: MP-TSCPC used with the above-described settings was unsuccessful in treating the majority of cases. Future studies should be targeted at primary glaucoma cases and with use of alternative laser settings.\",\"PeriodicalId\":23836,\"journal\":{\"name\":\"Veterinary ophthalmology\",\"volume\":\" \",\"pages\":\"465-473\"},\"PeriodicalIF\":1.7000,\"publicationDate\":\"2025-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Veterinary ophthalmology\",\"FirstCategoryId\":\"97\",\"ListUrlMain\":\"https://doi.org/10.1111/vop.13184\",\"RegionNum\":4,\"RegionCategory\":\"农林科学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/1/15 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"VETERINARY SCIENCES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Veterinary ophthalmology","FirstCategoryId":"97","ListUrlMain":"https://doi.org/10.1111/vop.13184","RegionNum":4,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/15 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"VETERINARY SCIENCES","Score":null,"Total":0}

引用次数: 0

摘要

目的描述微脉冲™经巩膜环形光凝术（MP-TSCPC）在青光眼马匹中的临床应用和治疗效果：方法：马匹在站立镇静状态下接受 MP-TSCPC 治疗，随访至少 30 天（30-1241 天不等）。对患眼用占空比为 31.3%、功率为 3000 mW 的激光进行治疗，共持续 180 秒。收集的数据包括信号、治疗前后的眼压、激光设置、药物、并发症和重复治疗：结果：四匹马（5 只眼）至少接受了一次 MP-TSCPC 治疗。术前平均眼压为 44 毫米汞柱（范围为 33-49 毫米汞柱）。术后即刻的平均眼压为 34 mmHg（4 只眼睛；范围 19-55 mmHg）。术后 1 周，眼压为 38 mmHg（5 只眼睛；范围为 21-80 mmHg）；术后 2 周，眼压为 40 mmHg（3 只眼睛；范围为 17-80 mmHg）；术后 1 个月，眼压为 35 mmHg（5 只眼睛；范围为 20-50 mmHg）；术后 3 个月，眼压为 18 mmHg（2 只眼睛；范围为 14-21 mmHg）；术后 6 个月，眼压为 35 mmHg（2 只眼睛；范围为 30-39 mmHg）；术后超过 300 天，眼压为 24 mmHg（3 只眼睛；范围为 18-29 mmHg）。并发症包括角膜溃疡（1 眼）、眼压失控（3 眼）和需要重复治疗（2 眼）：结论：在上述条件下使用 MP-TSCPC 治疗大多数病例并不成功。今后的研究应针对原发性青光眼病例，并使用其他激光设置。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

MicroPulse™ transscleral cyclophotocoagulation in the equine patient: A case series of four horses.

Objective: To describe the clinical application and outcome of MicroPulse™ transscleral cyclophotocoagulation (MP-TSCPC) treatment in horses with glaucoma.

Animals studied: Four client-owned horses with primary (n = 2) or secondary (n = 2) glaucoma.

Methods: Horses were treated with MP-TSCPC under standing sedation with a minimum of 30 days of follow-up (range 30-1241 days). Affected eyes were treated with a 31.3% duty cycle and 3000 mW laser power for a total of 180 s. Data collected included signalment, pre- and post-procedure intraocular pressures (IOPs), laser settings, medications, complications, and repeat therapy.

Results: Four horses (5 eyes) received at least one treatment with MP-TSCPC. Mean preoperative IOP was 44 mmHg (range 33-49 mmHg). The immediate mean postoperative IOP was 34 mmHg (4 eyes; range 19-55 mmHg). At 1 week, IOP was 38 mmHg (5 eyes; range 21-80 mmHg), at 2 weeks was 40 mmHg (3 eyes, range 17-80 mmHg), at 1 month was 35 mmHg (5 eyes; range 20-50 mmHg), at 3 months was 18 mmHg (2 eyes; range 14-21 mmHg), at 6 months was 35 mmHg (2 eyes; range 30-39 mmHg), and at >300 days was 24 mmHg (3 eyes; range 18-29 mmHg). Complications included corneal ulceration (n = 1 eye), uncontrolled IOP (n = 3 eyes), and need for repeat treatment (n = 2 eyes).

Conclusions: MP-TSCPC used with the above-described settings was unsuccessful in treating the majority of cases. Future studies should be targeted at primary glaucoma cases and with use of alternative laser settings.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Veterinary ophthalmology 农林科学-兽医学

CiteScore

2.70

自引率

37.50%

发文量

审稿时长

12-24 weeks

期刊介绍： Veterinary Ophthalmology is a peer-reviewed, international journal that welcomes submission of manuscripts directed towards academic researchers of veterinary ophthalmology, specialists and general practitioners with a strong ophthalmology interest. Articles include those relating to all aspects of: Clinical and investigational veterinary and comparative ophthalmology; Prospective and retrospective studies or reviews of naturally occurring ocular disease in veterinary species; Experimental models of both animal and human ocular disease in veterinary species; Anatomic studies of the animal eye; Physiological studies of the animal eye; Pharmacological studies of the animal eye.